- Home
- ADXN vs YCBD Comparison
ADXN vs YCBD Comparison
Compare ADXN & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- YCBD
- Stock Information
- Founded
- ADXN 2002
- YCBD 2015
- Country
- ADXN Switzerland
- YCBD United States
- Employees
- ADXN N/A
- YCBD N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- YCBD Health Care
- Exchange
- ADXN Nasdaq
- YCBD Nasdaq
- Market Cap
- ADXN 8.0M
- YCBD 7.8M
- IPO Year
- ADXN N/A
- YCBD N/A
- Fundamental
- Price
- ADXN $9.51
- YCBD $0.71
- Analyst Decision
- ADXN Strong Buy
- YCBD Strong Buy
- Analyst Count
- ADXN 1
- YCBD 1
- Target Price
- ADXN $30.00
- YCBD $2.00
- AVG Volume (30 Days)
- ADXN 60.1K
- YCBD 103.3K
- Earning Date
- ADXN 09-01-2025
- YCBD 08-14-2025
- Dividend Yield
- ADXN N/A
- YCBD N/A
- EPS Growth
- ADXN N/A
- YCBD N/A
- EPS
- ADXN 0.10
- YCBD N/A
- Revenue
- ADXN $278,508.00
- YCBD $19,026,064.00
- Revenue This Year
- ADXN $86.57
- YCBD $0.37
- Revenue Next Year
- ADXN N/A
- YCBD $4.95
- P/E Ratio
- ADXN $0.85
- YCBD N/A
- Revenue Growth
- ADXN N/A
- YCBD N/A
- 52 Week Low
- ADXN $6.51
- YCBD $0.59
- 52 Week High
- ADXN $12.05
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- ADXN 61.03
- YCBD 43.92
- Support Level
- ADXN $7.70
- YCBD $0.67
- Resistance Level
- ADXN $12.05
- YCBD $0.73
- Average True Range (ATR)
- ADXN 0.33
- YCBD 0.05
- MACD
- ADXN 0.22
- YCBD 0.00
- Stochastic Oscillator
- ADXN 41.61
- YCBD 23.62
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.